Toll-like receptors (TLRs) are pattern recognition receptors that play a central role in the innate immune system, recognizing pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs). TLRs are involved in the regulation of host immune responses, including the production of inflammatory cytokines and the activation of adaptive immune responses. TLRs are also implicated in the development of various diseases, including autoimmune disorders, chronic and acute inflammation, and cancer. TLR signaling pathways, such as the MyD88-dependent and TRIF-dependent pathways, are crucial for the regulation of inflammatory responses and the production of type I interferons. TLRs are expressed on various immune cells, including macrophages, dendritic cells, and B and T cells, and their activation can lead to the production of proinflammatory cytokines and the modulation of immune responses. TLRs are also involved in the development of various diseases, including respiratory, cardiovascular, digestive, endocrine, and sepsis-related conditions. TLRs are being explored as potential therapeutic targets for the treatment of inflammation-related diseases, autoimmune disorders, microbial infections, and cancers. The role of TLRs in disease development and progression is complex, and their modulation may offer new therapeutic strategies for the treatment of various diseases.Toll-like receptors (TLRs) are pattern recognition receptors that play a central role in the innate immune system, recognizing pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs). TLRs are involved in the regulation of host immune responses, including the production of inflammatory cytokines and the activation of adaptive immune responses. TLRs are also implicated in the development of various diseases, including autoimmune disorders, chronic and acute inflammation, and cancer. TLR signaling pathways, such as the MyD88-dependent and TRIF-dependent pathways, are crucial for the regulation of inflammatory responses and the production of type I interferons. TLRs are expressed on various immune cells, including macrophages, dendritic cells, and B and T cells, and their activation can lead to the production of proinflammatory cytokines and the modulation of immune responses. TLRs are also involved in the development of various diseases, including respiratory, cardiovascular, digestive, endocrine, and sepsis-related conditions. TLRs are being explored as potential therapeutic targets for the treatment of inflammation-related diseases, autoimmune disorders, microbial infections, and cancers. The role of TLRs in disease development and progression is complex, and their modulation may offer new therapeutic strategies for the treatment of various diseases.